How do I diagnose Reynaud's phenomenon in a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosing Raynaud's Phenomenon

Raynaud's phenomenon is primarily a clinical diagnosis based on the characteristic triphasic color change of the digits (white → blue → red) triggered by cold exposure or emotional stress, supplemented by laboratory testing and nailfold capillaroscopy to distinguish primary from secondary forms. 1, 2, 3

Clinical Diagnosis

The diagnosis relies on patient history describing the classic presentation:

  • Triphasic color change: Digits turn white (pallor from vasoconstriction), then blue (cyanosis), then red (reactive hyperemia) 2, 4
  • Triggering factors: Episodes provoked by cold exposure, humidity, vibration, or emotional stress 2, 4
  • Episodic nature: Attacks are reversible and paroxysmal, typically affecting fingers or toes 4

The clinical history alone establishes the diagnosis—no specific "test" is required to confirm Raynaud's phenomenon exists 3, 4

Distinguishing Primary from Secondary Raynaud's

Once Raynaud's is diagnosed clinically, the critical next step is determining whether it is primary (benign, idiopathic) or secondary to underlying disease:

Features Suggesting Primary Raynaud's:

  • Symmetric involvement of individual digits 5
  • Absence of digital ulcers, tissue necrosis, or gangrene 5
  • No systemic symptoms (joint pain, skin changes, weight loss, fever) 5, 6
  • Normal peripheral pulses 5
  • Typical discomfort only, not severe pain 1, 5

Red Flags for Secondary Raynaud's:

  • Asymmetric attacks or involvement of entire hand rather than individual digits 5, 6
  • Severe, painful episodes beyond typical discomfort 1, 5
  • Digital ulcers, tissue necrosis, or gangrene 1, 5, 6
  • Systemic symptoms: Joint pain, skin thickening, telangiectasias, weight loss, malaise, fatigue, fever, photosensitivity, dry eyes/mouth 5, 6
  • Abnormal or absent peripheral pulses suggesting atherosclerosis or thromboangiitis obliterans 5

Laboratory and Diagnostic Workup

For All Patients with Raynaud's:

  • Complete blood count with differential 1, 5, 7
  • Erythrocyte sedimentation rate (ESR) 1, 2, 4
  • Antinuclear antibodies (ANA) 1, 7, 2, 4
  • Nailfold capillaroscopy: Essential for early detection of underlying connective tissue disease; normal capillaries support primary Raynaud's 2, 4

Additional Testing When Secondary Raynaud's is Suspected:

  • Rheumatoid factor 1, 5, 7
  • Anticentromere antibodies and anti-Scl-70 antibodies (for systemic sclerosis) 1, 5
  • Anticardiolipin antibodies and lupus anticoagulant (for antiphospholipid syndrome) 1, 5
  • Ankle-brachial index (ABI): To exclude structural macro- or microvascular disease if peripheral arterial disease is suspected 1, 5
  • Digital photoplethysmography and pulse contour analysis: Can exclude structural vascular disease 4

Diagnostic Criteria for Primary Raynaud's:

Primary Raynaud's is diagnosed when ALL of the following are present 4:

  • Typical clinical symptoms
  • Normal ESR
  • Negative ANA
  • Normal nailfold capillaries
  • Absence of structural micro- or macrovascular damage
  • No evidence of underlying disease

Important Caveats

  • Upper extremity arterial testing (including ABI-equivalent studies) was rated as uncertain for Raynaud's phenomenon by ACC/AHA guidelines, suggesting it should not be routine unless there are specific concerns for structural vascular disease 8
  • The presence of Raynaud's phenomenon in the context of critical limb ischemia is a risk factor for limb loss, particularly when combined with diabetes, severe renal failure, or smoking 8
  • Systemic sclerosis is the most common underlying disease in secondary Raynaud's, with 22.5% of these patients developing digital ulcers 1, 5, 6
  • Patients with suspected thromboangiitis obliterans (Buerger's disease) should be specifically asked about tobacco use, as this is particularly associated with secondary Raynaud's in young smokers 1, 6

References

Guideline

Causes and Associations of Raynaud's Phenomenon

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Differential diagnoses of Raynaud's phenomenon].

Deutsche medizinische Wochenschrift (1946), 2014

Research

Raynaud’s phenomenon - assessment and differential diagnoses.

VASA. Zeitschrift fur Gefasskrankheiten, 2015

Guideline

Diagnosis and Management of Primary Raynaud's Phenomenon

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Causes and Clinical Features of Raynaud's Phenomenon

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

How to diagnose and manage a patient with suspected Raynaud's phenomenon?
What is the diagnosis and management for a patient presenting with Raynaud's (Raynaud's phenomenon) phenomenon, iron deficiency anemia, proteinuria, hematuria, non-blanching redness on the foot, petechiae, bilateral friction rub, and fatigue?
What is the assessment and treatment for a 42-year-old female with no past medical history who experiences episodic blue discoloration of her hands, particularly the fingertips, following a stressful event?
Are there any tests to confirm Raynaud's (Raynaud's phenomenon) or is it just a clinical diagnosis?
What is the diagnosis and management for a middle-aged woman with symptoms of Raynaud's phenomenon, including hand discoloration in cold water, chillblains, and no joint pains?
What is the primary treatment approach for an adult patient with Hand, Foot, and Mouth Disease (HFMD)?
What is the best management approach for a patient in their late 50s with a history of Cerebrovascular Accident (CVA), presenting with a moderately dilated aortic root and mildly dilated Ascending aorta?
Is tramadol (a synthetic opioid analgesic) safe to use in patients with impaired renal function (renal impairment) undergoing hemodialysis?
Why is midazolam preferred over Ativan (lorazepam) with droperidol for managing acute agitation in adult patients?
Can Anoro (umeclidinium and vilanterol) be used safely in a patient with a history of myocardial infarction (MI) and coronary artery bypass grafting?
What are the immediate management steps for a patient with a significantly elevated amphetamine level on a Urine Drug Screen (UDS), potentially indicating amphetamine toxicity or overdose?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.